DE SR23

Designates September 22-29, 2024, as "Frontotemporal Degeneration Awareness Week" in Delaware, coinciding with World FTD Awareness Week.

Recognizes that FTD is a terminal, incurable neurodegenerative disease affecting the frontal and temporal lobes that impairs speech, personality, behavior, and motor skills.

Notes that FTD diagnosis takes an average of 3.6 years, with life expectancy of 7-13 years after symptom onset, and predominantly affects people aged 45-64.

Highlights that FTD is the most common dementia form for people under 60, estimated to affect more than 60,000 Americans, with approximately 40 percent of cases having a family history.

States that FTD is often misdiagnosed as a psychiatric problem due to low public awareness, and that increased research and awareness efforts are needed to develop treatments and find a cure.